Name: ARS Pharmaceuticals, Inc. (SPRY) Balance Sheet
Creator: FinSpry

ARS Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for ARS Pharmaceuticals, Inc. (SPRY) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	50.82	228.36	274.38	60.06	24.52
Short-Term Investments	263.21	157.39	63.86	0.00	0.00
Cash & Short-Term Investments	314.02	228.36	274.38	60.06	24.52
Accounts Receivable	9.16	0.69	1.01	0.00	0.38
Inventory	5.21	0.00	0.00	0.00	0.00
Other Current Assets	4.67	0.64	2.96	0.67	1.48
Total Current Assets	334.30	231.73	277.70	60.73	26.38
Non-Current Assets
Property, Plant & Equipment (Net)	1.07	0.82	0.77	0.69	0.02
Intangible Assets	7.69	0.62	0.00	0.00	0.00
Other Non-Current Assets	8.11	0.02	2.96	0.02	0.00
Total Non-Current Assets	16.86	0.82	0.77	0.72	4.15
Total Assets	351.15	233.19	281.44	61.45	26.41
Current Liabilities
Accounts Payable	14.13	2.15	4.93	1.79	1.22
Short-Term Debt	0.04	0.00	0.00	3.48	2.56
Current Portion of Long-Term Debt	0.00	0.00	0.00	3.48	2.56
Accrued Liabilities	4.15	0.36	2.10	0.64	0.84
Deferred Revenue	0.56	0.00	0.28	1.46	3.52
Other Current Liabilities	4.57	1.04	1.00	0.02	0.08
Total Current Liabilities	23.44	2.39	5.44	8.19	8.21
Non-Current Liabilities
Long-Term Debt	69.38	0.04	0.25	4.93	7.46
Other Non-Current Liabilities	69.38	0.00	3.14	0.08	0.11
Total Non-Current Liabilities	70.92	0.04	3.11	84.53	2.33
Total Liabilities	94.36	2.43	8.55	92.72	19.23
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.00	0.22
Retained Earnings	-123.31	-131.25	-76.53	-42.26	-22.01
Accumulated Other Comprehensive Income	0.22	0.05	0.41	0.00	0.00
Additional Paid-in Capital	379.87	362.00	349.41	10.98	479.61
Shares Outstanding	97.95	96.41	93.94	93.77	0.00
Total Stockholders' Equity	256.80	230.76	272.89	-31.27	7.18
Total Liabilities & Equity	351.15	233.19	281.44	61.45	394.80